Adam Wadina is a Maywood, Illinois based neurologist who is specialized in Neurology. Active license number of Adam Wadina is 036.171005 for Neurology in Illinois. His current practice location is 2160 S 1st Ave, Maywood. Patients can reach him at 888-584-7888. Adam Wadina is MD in Neurology and his NPI number (Unique professional ID assigned by NPPES) is 1073141792. Adam Wadina specializes in the diagnosis and treatment of diseases or impaired function of the brain, spinal cord, peripheral nerves, muscles, autonomic nervous system, and blood vessels that relate to these structures.
Complete Profile:
Adam Wadina speciality, credentials, practice address, contact phone number and fax are as below.
Patients can call on the below given phone number for appointment.
Name:
Adam Wadina
Specialization:
Neurology
Gender:
Male
Credentials:
MD
Practice Address:
2160 S 1st Ave, Maywood, Illinois, 60153-3328
Phone:
888-584-7888
Professional Identification Codes:
NPI number stands for National Provider Identifier which is a unique 10-digit identification number issued to health care providers in the United States by the Centers for Medicare and Medicaid Services (CMS).
NPI details are as mentioned below.
NPI Number:
1073141792
NPI Enumeration Date:
29 Mar, 2020
NPI Last Update On:
25 Jul, 2024
Medical Licenses:
Doctors can have one or more medical licenses for different specialities in the same state or different states. Related medical licenses for Adam Wadina are as mentioned below.
License Number
Specialization
State
Status
036.171005
Neurology
Illinois
Primary
Business Mailing Address:
Business mailing address can be used for mailing purpose only, for visiting purpose patients need to refer above mentioned address.
Address:
Adam Wadina 2160 S 1st Ave, Maywood, Illinois
Zip:
60153-3328
Patients can reach Adam Wadina at 2160 S 1st Ave, Maywood, Illinois or can call to book an appointment on 888-584-7888.
Comments/ Reviews:
*Data of this site is collected from Medicare & Medicaid Services (CMS) and NPPES. Last updated on 11 November, 2024.